Caitlin Raymond on Platelet Refractoriness: New Series Alert!
Caitlin Raymond, a board-certified Clinical Pathologist and current Transfusion Medicine Fellow at the National Institutes of Health, shared on LinkedIn:
“New Blog Post: Platelet Refractoriness — An Overview
One of the most frustrating challenges in transfusion medicine is when platelet transfusions don’t “stick.”
Platelet refractoriness is common, multifactorial, and has huge implications for bleeding risk, patient outcomes, and stewardship of scarce blood products.
In this post, I walk through:
- How we define and measure refractoriness (CCI)
- Why non-immune causes (like sepsis, bleeding, or splenomegaly) are the most common and should be ruled out first
- How we evaluate immune causes with HLA typing, antibody screens, PRA, and crossmatches
- Practical management strategies, from HLA-compatible platelets to PRA-guided selection
- The real-world challenges of balancing ideal care with limited resources
Key takeaway: Refractoriness isn’t rare—and a structured approach can make transfusion both safer for patients and more sustainable for the blood supply.”
Read the full post here.
More from Caitlin Raymond featured in HT!
More series on coagulation featured in Hemostasis Today.
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?
-
Aug 26, 2026, 09:01Mary Cushman: The Role of IL-6 in Cardiovascular Disease
-
Aug 26, 2026, 07:49Linda Koch: Understanding Ageing Through Biological Transitions
-
Aug 26, 2026, 05:38Elias Lee։ Beyond MCA Stenosis – Recognizing Moyamoya
-
Aug 26, 2026, 03:46Hugo Ribeiro: Which NSAIDs Are Safest for Older Adults?